Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models.
about
Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Dual PPARα/γ agonist saroglita ...... y in experimental NASH models.
@en
Dual PPARα/γ agonist saroglita ...... y in experimental NASH models.
@nl
type
label
Dual PPARα/γ agonist saroglita ...... y in experimental NASH models.
@en
Dual PPARα/γ agonist saroglita ...... y in experimental NASH models.
@nl
prefLabel
Dual PPARα/γ agonist saroglita ...... y in experimental NASH models.
@en
Dual PPARα/γ agonist saroglita ...... y in experimental NASH models.
@nl
P2093
P2860
P356
P1433
P1476
Dual PPARα/γ agonist saroglita ...... y in experimental NASH models.
@en
P2093
Akshyaya Rath
Bibhuti Bhoi
Chitrang Trivedi
Eshani Karmakar
Hiren Patel
Mukul R Jain
Nabanita Das
Pankaj R Patel
Prabodha Swain
Ramchandra Ranvir
P2860
P304
P356
10.1111/LIV.13634
P577
2017-12-14T00:00:00Z